Brain cholesterol: long secret life behind a barrier.
Level 5 - mechanism / opinion, no new human data
Narrative review describing physiological mechanisms without systematic search or primary empirical data.
PubMed 14764421 · doi:10.1161/01.ATV.0000120374.59826.1b
What was done
Narrative review synthesizing findings on brain cholesterol homeostasis, focusing on local de novo synthesis, apolipoprotein-dependent recycling, blood-brain barrier compartmentalization, oxysterol excretion pathways, and potential relevance to neurodegenerative disorders such as Alzheimer disease.
What was found
Approximately 25% of total human body cholesterol resides in the brain, predominantly in myelin. Nearly all brain cholesterol originates from local synthesis because the blood-brain barrier blocks exchange with circulating lipoprotein cholesterol. Under steady-state conditions, de novo synthesis is balanced by the conversion to and excretion of 24S-hydroxycholesterol into the circulation. The abstract provides no quantitative clinical outcome data and notes that existing studies permit no firm conclusions regarding whether cholesterol synthesis inhibitors reduce Alzheimer disease prevalence.
Why it matters
This paper outlines the compartmentalization of cerebral cholesterol metabolism from peripheral circulation and defines the role of 24S-hydroxycholesterol in brain cholesterol elimination.
Limits
This is a narrative review lacking systematic search methodology and primary experimental data. Clinical associations between brain cholesterol turnover, statin use, and Alzheimer disease prevention remain unproven based on the presented evidence.
Cited by
- supports The human brain does not take up cholesterol from the bloodstream, but synthesizes its own cholesterol locally.